HMOX1 and hepatocellular carcinoma: Furthermore, HO-1 overexpression was described to impair tumor progression of non-small cell lung carcinoma cells [71], hepatocellular carcinoma cells [72], and triple-negative breast cancer cells [73] resulting in apoptotic cell death.